Biotech Values

[DewDiligence]

Someone else liked the IDIX presentation at JPM yesterday, evidently.

I thought it the presentation was very impressive, albeit difficult to follow for investors without a technical background in the antiviral arena. JP Sommadossi often speaks as though his audience is a group of medicinal chemists, and his thick Marseille accent doesn’t help.